Biologic Therapies VII: Precision Medicine in the Biologic Era
In the Biologic Therapies VII: Precision Medicine in the Biologic Era online series, an international, multi-disciplinary faculty of experts critically appraise recent basic laboratory breakthroughs in terms of their potential clinical implications and provide in-depth analyses of approved agents, new agents, predicting toxicity, clinical controversies, and new indications.
- Describe recent advances in biologic drug development, regulations, and indications in immune-mediated inflammatory diseases (IMIDs).
- Critically appraise data on genetics and personalized medicine as applied to rheumatic diseases and IMIDs.
- Analyze recent investigations on efficacy and toxicity of biologic agents across IMIDs.
- Detail current knowledge related to predicting outcomes in patients with rheumatoid arthritis (RA).
- Summarize updates in diagnosis, classification, therapies, and immune-system targets in both psoriatic arthritis (PsA) and spondyloarthopathies (SpA) and describe their clinical implications.
- Critically assess clinical data on biologic use in immune-related diseases in the areas of pulmonary disease, dermatology, metabolic bone diseases, and systemic lupus erythematosus (SLE).
- Develop strategies to predict, prevent, and treat comorbid complications of biologic therapy including cardiovascular disease and serious infections.
The online series is designed for rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, and associated allied health practitioners, including nurse practitioners, nurses, and physician assistants interested in or using biologic therapeutics for autoimmune and inflammatory disorders.
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Department of Rheumatic and Immunologic Diseases
M. Elaine Husni, MD, MPH
Director, Arthritis and Musculoskeletal Treatment Center
Vice Chair, Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute